EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link: https://ebookbell.com/faq

We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.

For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Pediatric Cancer Therapeutics Development Jorge Dimartino Gregory H Reaman

Name: Pediatric Cancer Therapeutics Development Jorge Dimartino Gregory H Reaman
SKU: BELL-47298570
Price: 31.00 USD
Availability: InStock
Rating: 4.4 (92 reviews)

SKU: BELL-47298570

$ 31.00 ~~$ 45.00~~ (-31%)

4.4

92 reviews

Pediatric Cancer Therapeutics Development Jorge Dimartino Gregory H Reaman instant download after payment.

Publisher: Springer

File Extension: PDF

File size: 9.03 MB

Pages: 183

Author: Jorge DiMartino, Gregory H. Reaman, Franklin O. Smith

ISBN: 9783031063565, 3031063562

Language: English

Year: 2022

Product desciption

Pediatric Cancer Therapeutics Development Jorge Dimartino Gregory H Reaman by Jorge Dimartino, Gregory H. Reaman, Franklin O. Smith 9783031063565, 3031063562 instant download after payment.

This book provides a comprehensive overview of the scientific, medical, regulatory, and economic considerations associated with the discovery, development, and delivery of novel therapeutics for children with cancer. Co-authored by a diverse team from academic, government, and industry backgrounds, the book describes the steps in the process from the identification of a promising therapeutic target to the evaluation of drug candidates in the various phases of clinical testing and regulatory review. Throughout, special emphasis is placed on the unique biology of pediatric malignancies and the medical and social needs of children and their families. In providing a firm grounding in the drug development process, the book will be of value to all with an interest in how medicines currently used to treat pediatric cancer were made available. This includes trainees as well as established practitioners and others participating in translational and clinical research in the academic setting.